MNPR (STOCKS)
Monopar Therapeutics Inc. Common Stock
$71.800000
-1.300000 (-1.78%)
Prev close: $73.100000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Chandler Drew Robinson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $482.81M
- Employees
- 16
- P/E (TTM)
- -31.27
- P/B (TTM)
- 3.75
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
13
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.62 | $-0.63 | +0.0135 | +2.13% |
|
Mar 2026 (Q1)
|
$-0.46 | $-0.85 | +0.3921 | +46.02% |
|
Dec 2025 (Q4)
|
$-0.64 | $-0.50 | -0.1372 | -27.29% |
|
Sep 2025 (Q3)
|
$-0.48 | $-0.44 | -0.0414 | -9.44% |